<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1337566</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2023.1337566</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: NMR-based metabolomics</article-title>
<alt-title alt-title-type="left-running-head">Junot et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2023.1337566">10.3389/fmolb.2023.1337566</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Junot</surname>
<given-names>Christophe</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1364358/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinu</surname>
<given-names>Farhana R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/368293/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Hooft</surname>
<given-names>Justin J. J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/175831/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Moco</surname>
<given-names>Sofia</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/82628/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Universit&#xe9; Paris-Saclay</institution>, <institution>CEA</institution>, <institution>INRAE</institution>, <institution>D&#xe9;partement M&#xe9;dicaments et Technologies pour La Sant&#xe9; (MTS)</institution>, <addr-line>Gif-sur-Yvette</addr-line>, <country>France</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Biological Chemistry and Bioactives Group</institution>, <institution>The New Zealand Institute for Plant and Food Research Ltd.</institution>, <addr-line>Auckland</addr-line>, <country>New Zealand</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Bioinformatics Group</institution>, <institution>Wageningen University &#x26; Research</institution>, <addr-line>Wageningen</addr-line>, <country>Netherlands</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Molecular and Computational Toxicology</institution>, <institution>Chemistry and Pharmaceutical Sciences Department</institution>, <institution>AIMMS</institution>, <institution>Vrije Universiteit Amsterdam</institution>, <addr-line>Amsterdam</addr-line>, <country>Netherlands</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/13413/overview">Wolfram Weckwerth</ext-link>, University of Vienna, Austria</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Sofia Moco, <email>s.moco@vu.nl</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>10</volume>
<elocation-id>1337566</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Junot, Pinu, van der Hooft and Moco.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Junot, Pinu, van der Hooft and Moco</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Mol. Biosci." xlink:href="https://www.frontiersin.org/researchtopic/41791" ext-link-type="uri">Editorial on the Research Topic <article-title>NMR-based metabolomics</article-title> </related-article>
<kwd-group>
<kwd>metabolomics</kwd>
<kwd>NMR</kwd>
<kwd>metabolite</kwd>
<kwd>metabolism</kwd>
<kwd>sample preparation</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Metabolomics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Nuclear magnetic resonance (NMR) spectroscopy has a longstanding history in the analysis of biological small molecules (<xref ref-type="bibr" rid="B1">Jardetzky and Jardetzky, 1960</xref>). NMR is probably the most recognized spectroscopy able to provide decisive chemical information to elucidate molecular structures. With the rise of metabolomics, NMR entered a new area (<xref ref-type="bibr" rid="B3">Nicholson et al., 1999</xref>). The opportunity to use NMR to detect many metabolites in complex biological samples has led to important technology- and application-driven developments.</p>
<p>Improvements in sensitivity with the introduction of cryogenic probes, high magnetic field strengths, and automation during NMR acquisition have contributed to the robustness of modern high-resolution instruments. These hardware improvements were matched with many developments at the application level, e.g., dedicated pulse sequences allowing for flat baselines and efficient water suppression, and these have helped in the standardization of NMR procedures in metabolomics. Computational tools, including the availability of NMR spectral databases, have tremendously improved the consistency in metabolite identification and integration. As a result, &#x201c;<italic>NMR-based metabolomics</italic>&#x201d; is nowadays applied in a wide variety of fields from natural product research (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.725691/full">Alfattani et al.</ext-link>) to clinical (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2023.1125582/full">Madrid-Gambin et al.</ext-link>) and biomedical applications (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.785232/full">Zhong et al.</ext-link>).</p>
<p>NMR has managed to establish its niche within metabolomics as a result of important advantages, such as being robust, unbiased, and quantitative, remaining the spectroscopy to rely on for structure elucidation (<xref ref-type="bibr" rid="B2">Moco, 2022</xref>; <xref ref-type="bibr" rid="B4">Wishart et al., 2022</xref>).</p>
<p>Given the robustness and quantitative nature of NMR, the analysis of large human cohorts, including biobanks, has been an area of great expansion in &#x201c;<italic>NMR-based metabolomics</italic>.&#x201d; Given the sheer number of analyses, that can sometimes number in the 1,000s and often involve multiple centra of sampling and NMR acquisition, reproducibility and stability become central. The effect of various sample preparation protocols on the NMR quantification of 43 human plasma metabolites was assessed (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2023.1125582/full">Madrid-Gambin et al.</ext-link>). Four different approaches were tested: simple buffer addition was compared to ultrafiltration, protein precipitation with methanol, and glycerophospholipid solid-phase extraction (g-SPE) before buffer addition. While some of these methods seem more effective for protein and lipid removal from NMR spectra, differences in absolute concentrations were found. Hence, the complete and accurate reporting of procedures becomes of utmost importance when attempting to compare studies at the quantitative level.</p>
<p>While NMR may never compete with the sensitivity of mass spectrometry (MS), in combination, these two techniques are powerful in describing metabolomes (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.725691/full">Alfattani et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.720955/full">Ghosh et al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.785232/full">Zhong et al.</ext-link>). Combined techniques such as liquid chromatography (LC)-solid phase extraction (SPE)-NMR/MS have been around for a while; the combination with cryogenic electron microscopy (cryoEM) was discussed by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.720955/full">Ghosh et al.</ext-link> as a strategy to further expand metabolite identification (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.720955/full">Ghosh et al.</ext-link>). Microcrystal electron diffraction or microED is a cryoEM method that can precisely determine the structure of metabolites. From a complex natural product extract, a workflow integrating separation by LC, MS analysis, and SPE isolation of candidate metabolites, followed by parallel NMR acquisition and production of crystals for cryo-EM analysis is discussed.</p>
<p>Another strategy to enhance the capacity of metabolite identification is proposed by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.725691/full">Alfattani et al.</ext-link> Semi-preparative LC time-slice fractionation before NMR acquisition allowed for the assembly of a &#x201c;pseudo-LC-NMR&#x201d; 2D contour map that could be paired with parallel LC-MS analyses. This high-resolution NMR-MS combination worked through molecular networks and unveiled novel metabolites present in the Mediterranean seagrass <italic>Fusarium petroliphilum</italic>. This approach will be useful in the identification of natural products in bioactive extracts of similar polarity (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.725691/full">Alfattani et al.</ext-link>).</p>
<p>Imaging techniques are important to locate specific metabolic niches in biological samples associated with disease. Magic angle spinning (MAS)-NMR has been compared and combined with matrix-assisted laser desorption ionization (MALDI)-MS to image human cancers (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.785232/full">Zhong et al.</ext-link>). The possibility of integrating both NMR and MS spectral data from human tissue images will assist their use in the diagnosis and classification of cancer types.</p>
<p>In summary, a series of original publications were gathered in this Research Topic, showcasing the multifaceted character of NMR. Various fields of research are presented, as well as the powerful alliance of NMR with MS in various applications toward improving metabolite identification, annotation, and structure elucidation. Taken together, &#x201c;<italic>NMR-based metabolomics</italic>&#x201d; is here to stay.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>CJ: Writing&#x2013;review and editing. FP: Writing&#x2013;review and editing. JH: Writing&#x2013;review and editing. SM: Writing&#x2013;original draft, Writing&#x2013;review and editing.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>Author FP was employed by The New Zealand Institute for Plant and Food Research Ltd. JH is currently a member of the Scientific Advisory Board of NAICONS Srl., Milano, Italy, and is consulting for Corteva Agriscience, Indianapolis, IN, United States.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jardetzky</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Jardetzky</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>1960</year>). <article-title>Investigation of the structure of purines, pyrimidines, ribose nucleosides and nucleotides by proton magnetic resonance. II <sup>1</sup>
</article-title>. <source>J. Am. Chem. Soc.</source> <volume>82</volume>, <fpage>222</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1021/ja01486a050</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moco</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Studying metabolism by NMR-based metabolomics</article-title>. <source>Front. Mol. Biosci.</source> <volume>9</volume>, <fpage>882487</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2022.882487</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Lindon</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>&#x201c;Metabonomics&#x201d;: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data</article-title>. <source>Xenobiotica</source> <volume>29</volume>, <fpage>1181</fpage>&#x2013;<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1080/004982599238047</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wishart</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Copi&#xe9;</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Edison</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Eghbalnia</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Hoch</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>NMR and metabolomics&#x2014;a roadmap for the future</article-title>. <source>Metabolites</source> <volume>12</volume>, <fpage>678</fpage>. <pub-id pub-id-type="doi">10.3390/metabo12080678</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>